PPT-The Future Control of Cervical Cancer

Hazel Lewis Public Health Physician Wellington Cartwright Forum 7 August 2015 NCSP R centralised 1965 1990 2000 1988 Cartwright Report NCSP established In 14 AHB 1996 NSU Gisborne Inquiry CSI. . KrisEmily. . McCrory. , MD. Objectives:. Review cervical cancer epidemiology and . pathophysiology. Identify the role of the Human . Papilloma. Virus in cervical cancer. Explain the use of HPV testing in cervical cancer screening. Based on 2012 Guidelines & Recommendations. Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Interactions and Interventions. Jean R. Anderson, M.D.. Jhpiego, an affiliate of Johns Hopkins University. The Johns Hopkins University School of Medicine. Cervical Cancer. Latest data on cervical cancer incidence and mortality (GLOBOCAN 2008, IARC*):. The Obstetrics & Gynecological Society of Bhopal. &. AMPOGS Research Public Welfare Society. BREAST . AND GENITAL TRACT CANCER INCIDENCE RATES PER 100,000 . FEMALES worldwide. 31.3. 17.4. 8.3. 141. st. APHA Annual Meeting. November 2013. Richard A. Crosby, PhD. University of Kentucky College of Public Health. Department of Health Behavior. . Presenter Disclosures. (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months:. Cervical Cancer Statistics. United . States. An estimated 12,000 new cases each year. An estimated 4,000 . deaths . each year . 700,000 cases of severe . pre-cancer . International. Approximately 500,000 cases expected worldwide each year!. By Beshair Nurhussien, Agnes Nantambi, and Allison Wood. Worcester Technical High, Doherty Memorial, Doherty Memorial. 1. Health Disparity. “Difference in the incidence, prevalence mortality, and other adverse health conditions that exist among specific population groups.” . A Resident’s Primer. Presented as an education exhibit at the 2014 RSNA Annual Meeting – OBE117.. All authors have disclosed no relevant relationships.. Anish . Raithatha. , BSc, MBBS,. 1*. . Ioanna. Megan Swanson, MD MPH. Assistant Professor. Gynecologic Oncology. UCSF. Limited effective treatment options for advanced cervical cancer. Problem. : when cervical cancer is . advanced. and/or recurrent . Dr. Seema Singhal . Department of Obstetrics and . Gynaecology. . AIIMS New Delhi . Cervical cancer disease burden . Global Incidence and mortality in 2018 . India : Major contributor to global burden of cervical cancer . CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. Cervical cancer. Cervical cancer is one of the . most preventable . cancers. Human papillomavirus (HPV). Over 99% of cervical cancer is caused by HPV. ‘Common cold of sexual activity’. Usually no symptoms. Utah Academy of Family Physicians, 11/7/20. Clara . Keegan, . MD, FAAFP. University of Vermont Department of Family Medicine. After this activity, I hope you will be able to …. Summarize the natural history of HPV as it relates to cervical cancer screening.. (Preliminary Results). Hawa Camara. |. November 17. th. , 2018. Facts about Cervical cancer in PNG. 2. Experiences of PoC HPV-DNA cervical screening in PNG. Need for improved screening services. 3.